Selvita (WAR:SLV) ROE % Adjusted to Book Value: -3.36% (As of Mar. 2026)

Selvita WAR:SLV +2.58% 82 ROE % Adjusted to Book Value is -3.36% as of Mar. 2026. GuruFocus rates WAR:SLV with a GF Score™ of 82/100 and a GF Value™ of zł58.46 (Significantly Undervalued). The stock has 4 warning signs investors should review.

Selvita's ROE % for the quarter that ended in Mar. 2026 was -6.82%. Selvita's PB Ratio for the quarter that ended in Mar. 2026 was 2.03. Selvita's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2026 was -3.36%.

Selvita ROE % Adjusted to Book Value Related Terms

Selvita ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for Selvita's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Selvita ROE % Adjusted to Book Value Chart

Selvita Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

1.13

2.28

7.23

-0.67

0.10

Selvita Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															-0.54	-3.31	-0.53	3.74	-3.36

WAR:SLV vs TMO, DHR, IDXX: ROE % Adjusted to Book Value Comparison

For the Diagnostics & Research subindustry, Selvita's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Selvita ROE % Adjusted to Book Value vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Selvita's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Selvita's ROE % Adjusted to Book Value falls into.

Save Embed

82GF Score

Selvita SA WAR:SLV

ROE % Adjusted to Book Value is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Selvita ROE % Adjusted to Book Value Calculation

Selvita's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2025 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	0.25%	/	2.46
	=	0.10%

Selvita's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2026 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-6.82%	/	2.03
	=	-3.36%

Frequently Asked Questions Learn more about ROE % Adjusted to Book Value →

What does a ROE % Adjusted to Book Value of -3.36% mean?

Selvita (WAR:SLV) has a ROE % Adjusted to Book Value of -3.36% as of Mar. 2026. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Selvita and its competitors.

Is Selvita's ROE % Adjusted to Book Value too high?

Selvita's current ROE % Adjusted to Book Value is -3.36%. Overall, Selvita has a GF Score™ of 82/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.

How does Selvita's ROE % Adjusted to Book Value compare to TMO and DHR?

Selvita's ROE % Adjusted to Book Value of -3.36% can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good ROE % Adjusted to Book Value for a Medical Diagnostics & Research company?

A good ROE % Adjusted to Book Value depends on the Medical Diagnostics & Research industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high ROE % Adjusted to Book Value mean?

A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Selvita and its competitors. Selvita's current ROE % Adjusted to Book Value is -3.36%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Selvita stock overvalued right now?

Based on GuruFocus' analysis, Selvita (WAR:SLV) is currently considered Significantly Undervalued. The stock's GF Value™ is zł58.46, compared to a current price of zł31.80 — trading 45.6% below its estimated fair value. The current ROE % Adjusted to Book Value is -3.36%. Selvita's overall GF Score™ is 82/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is ROE % Adjusted to Book Value calculated?

ROE % Adjusted to Book Value is calculated from a company's financial statements. For Selvita (WAR:SLV), the current ROE % Adjusted to Book Value is -3.36% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Selvita (WAR:SLV) Overvalued in 2026?

Based on GuruFocus' analysis, Selvita stock appears to be undervalued. The current stock price of zł31.80 is trading 45.6% below its estimated GF Value™ of zł58.46. GuruFocus considers Selvita to be Significantly Undervalued.

Key valuation signals for WAR:SLV:

ROE % Adjusted to Book Value: -3.36%
GF Value™: zł58.46 vs. price of zł31.80 (45.6% below fair value)
GF Score™: 82/100 with 4 warning signs

No single metric tells the full story. See the WAR:SLV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Selvita Business Description

Industry Healthcare Medical Diagnostics & Research

Comparable Companies WAR:SCP WAR:BMX WAR:GEN WAR:VOX TMO DHR SHSE:603259 XSWX:LONN IDXX A NTRA WAT IQV ILMN MTD DGX LH GH MEDP XPAR:ERF

Other Exchanges 787:Germany

Address Bobrzynskiego 14, Park Life Science, Krakow, POL, 30-348

Website https://www.selvita.com

Selvita SA is a Poland based parent company of Selvita Group is one of the largest preclinical contract research organizations in Europe. It also develops bioinformatics solutions supporting innovative projects at preclinical stages. It also provides services provided to external contractors are in the field of chemistry, analytics, regulatory, biochemistry and cell biology and also the integrated research and development projects.

82GF Score

Get the complete analysis for WAR:SLV

ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł31.80

Price

zł58.46

GF Value

View WAR:SLV Analysis

See ROE % Adjusted to Book Value data for all stocks →